Rayonier Advanced Matls Inc Stock Price, News & Analysis

Rayonier Advanced Materials (NYSE: RYAM), the global leader in High Purity Cellulose, has announced its senior management's participation in two upcoming equity conferences in Boston. Joshua Hicks, Senior Vice President of High Purity Cellulose, will present at the KeyBanc Capital Markets Industrials & Basic Materials Conference on May 29, 2025. Additionally, Marcus Moeltner, CFO and Senior VP of Finance, will attend the Stifel 2025 Boston Cross Sector 1x1 Conference on June 3, 2025. Both events will take place at the InterContinental Boston, with one-on-one meetings available upon request.

Rayonier Advanced Materials (NYSE: RYAM), the global leader in High Purity Cellulose, has announced an upcoming fireside chat featuring CFO and Senior VP of Finance, Marcus Moeltner, with Water Tower Research analyst Dmitry Silversteyn. The discussion, scheduled for May 21, 2025, at 2:00 PM ET, will focus on key business aspects including:

• RYAM's new segment reporting
• Optimization strategies for Cellulose Specialties and Commodities businesses
• Growth plans for the Biomaterials business

Interested participants can register through RYAM.com or via the provided direct link.

RYAM reported challenging Q1 2025 results with net sales of $356M (down $32M YoY) and a net loss of $32M ($0.49 per share). Adjusted EBITDA was $17M, including a $12M non-cash environmental charge. Key challenges included lower cellulose specialties sales volumes, higher input costs, operational issues, and soft demand in Paperboard and High-Yield Pulp. The company faces significant headwinds from Chinese tariffs, with approximately $85M in annual revenue exposed to 125% import tariffs. Due to these challenges, RYAM revised its 2025 guidance to Adjusted EBITDA of $175-185M and Adjusted Free Cash Flow of $5-15M. The company maintains a solid balance sheet with total debt of $736M and a net secured leverage ratio of 2.9x.

Rayonier Advanced Materials (NYSE: RYAM) has announced its upcoming first quarter 2025 earnings release schedule. The company will disclose its financial results on Tuesday, May 6, 2025, after market hours.

Key event details:

• Earnings Conference Call: Wednesday, May 7, 2025, at 9:00 a.m. ET
• Dial-in Numbers: - US: 877-407-8293 (no passcode needed) - International: 201-689-8349
• Replay Access: Available until May 21, 2025, at 6:00 p.m. ET - US: 877-660-6853 - International: 201-612-7415 - Conference ID: 13750563

Investors can access supplemental materials and the live audio webcast at www.RYAM.com. A replay of the webcast will be archived on the company's website shortly after the call concludes.

Rayonier Advanced Materials (NYSE: RYAM), the global leader in High Purity Cellulose, has announced its senior management's participation in two major equity conferences this March. CFO and SVP Finance Marcus Moeltner will present at the Sidoti Small Cap Equity Conference on March 19 at 12:15 PM EST. Following this, President and CEO De Lyle Bloomquist will speak at the Gabelli Funds 16th Annual Specialty Chemicals Symposium on March 20 at 1:30 PM EST.

Both events will offer opportunities for one-on-one meetings with management upon request, with registration available through provided links.

Rayonier Advanced Materials (RYAM) reported its Q4 and full-year 2024 results, showing mixed performance. Net sales reached $1,630 million, slightly down $13 million from 2023. The company reduced its loss from continuing operations to $42 million, a $60 million improvement year-over-year.

Key financial metrics include Adjusted EBITDA of $222 million (up $83 million), total debt of $730 million, and Net Secured Debt of $625 million. The company generated $203 million from operating activities and $128 million in Adjusted Free Cash Flow.

Strategic highlights include reducing commodity market exposure, securing €67 million in capital commitments for biomaterials investments, and completing a five-year loan refinancing. For 2025, RYAM projects Adjusted EBITDA guidance of $215-235 million and Adjusted Free Cash Flow of $25-45 million, with a negotiated mid-single-digit price increase for cellulose specialties.

Rayonier Advanced Materials (NYSE: RYAM) has announced it will release its fourth quarter 2024 earnings on Wednesday, March 5, 2025, after market close. The company will host a conference call and live webcast the following day, Thursday, March 6, 2025, at 9:00 a.m. ET to discuss the results.

Investors can access the conference call by dialing 877-407-8293 (U.S.) or 201-689-8349 (international). A replay will be available until March 20, 2025, accessible via U.S. number 877-660-6853 or international number 201-612-7415 (Conference ID: 13750562). Supplemental materials and webcast access will be available at www.RYAM.com, with a replay archived on the website after the call.

Rayonier Advanced Materials (RYAM) released preliminary financial results for fiscal year 2024, showing mixed performance. Net sales reached $1,639 million, slightly down by $4 million year-over-year, while loss from continuing operations improved by $59 million to $43 million.

Adjusted EBITDA saw significant growth, increasing 60% to $222 million from $139 million in 2023, with margin improving to 13.5% from 8.5%. The company generated $205 million in operating cash flow, up $69 million from prior year, and achieved $130 million in adjusted free cash flow.

Looking ahead to 2025, RYAM projects mid-single-digit percentage increases in Cellulose Specialties prices, though volumes are expected to decline due to Temiscaming plant suspension. The company faces potential impacts from proposed 25% tariffs on Canadian Paperboard exports to the U.S., which could affect up to $3.5 million monthly.

Rayonier Advanced Materials (RYAM) has secured €67 million in green capital financing, comprising €37 million in secured term loans from French banks at ~5% interest rate with 7-year maturity, and €30 million in preferred equity from Swen Capital Partners. The latter investment represents a 20% stake in RYAM BioNova S.A.S., valuing the new entity at over $160 million. The funds will support BioNova's growth initiatives, including a second-generation bioethanol plant and prebiotics project, with projected EBITDA of over $40 million by 2027.